Intravenous immunoglobulin for refractory eosinophilic fasciitis: A retrospective analysis from 3 tertiary care centers - 01/06/23
Doi : 10.1016/j.jaad.2019.12.022
Elizabeth Tkachenko, BS a, b, Alexa B. Steuer, MPH c, Kelly Lo, BS b, Gabriela Cobos, MD b, Kristen Lo Sicco, MD c, Ruth Ann Vleugels, MD, MPH b, Alisa N. Femia, MD c, ⁎ 
a University of Massachusetts Medical School, Worcester, Massachusetts
b Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
c The Ronald O. Perelman Department of Dermatology, New York University Langone Medical Center, New York
∗Correspondence to: Alisa N. Femia, MD, The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, 240 East 38th St, 11th Floor, New York, NY 10016The Ronald O. Perelman Department of DermatologyNew York University School of Medicine240 East 38th St, 11th FloorNew YorkNY10016
| Ms Tkachenko and Ms Steuer are cofirst authors. Drs Vleugels and Femia and cosenior authors. |
|
| Funding sources: Dr Vleugels's career has been supported by a Medical Dermatology Career Development Award from the Dermatology Foundation. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Approved by XXXX. |
© 2023
Publié par Elsevier Masson SAS.
Vol 88 - N° 6
P. 1354-1356 - juin 2023 Retour au numéro
Article précédent
- Detecting elder abuse in dermatology: A clinical and practical review
- Alexandria Brown, Soo Jung Kim
- Challenges to intersectional analyses and building capacity for skin cancer research in minority populations
- Ameya Gangal, Krittin J. Supapannachart, Suephy C. Chen, Howa Yeung
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?